Related Experiment Video
Updated: Jan 18, 2026

Combining Human Organoids and Organ-on-a-Chip Technology to Model Intestinal Region-Specific Functionality
Published on: May 5, 2022
Organoids for disease modeling and treatment: state-of-the-art.
Mingyi Xu1,2, Dexiao Kong3, Shan Sun4
1Shandong Provincial Key Medical and Health Laboratory of Blood Ecology and Biointelligence, Jinan Key Laboratory of Medical Cell Bioengineering, Science and Technology Innovation Center, The Fourth People's Hospital of Jinan Affiliated to Shandong Second Medical University, 50 Shifan Road, Tianqiao District, Jinan, 250031, China.
Organoid technology, using stem cells to create 3D organ models, revolutionizes regenerative medicine and biomedical research by enabling better disease modeling and drug screening for precision medicine.
Area of Science:
- Biomedical Research
- Regenerative Medicine
- Developmental Biology
Background:
- Organoids are 3D micro-organ models derived from stem cells.
- They faithfully recapitulate physiological and pathological conditions of human organs.
- Organoid technology overcomes limitations of traditional model systems.
Purpose of the Study:
- To review organoid construction principles and multidisciplinary integration.
- To summarize organoid applications in disease modeling and pharmaceutical research.
- To discuss prospects and challenges in organoid-based clinical applications.
Main Methods:
- Comprehensive review of organoid construction principles.
- Systematic summary of organoid applications.
- Analysis of organoid-based clinical trials and challenges.
Main Results:
- Organoids offer unprecedented avenues for organogenesis research, disease modeling, and drug screening.
- Applications span from basic research to individualized therapeutics and clinical trials.
- Key challenges include vascularization, standardization, and ethical considerations.
Conclusions:
- Organoid technology is a state-of-the-art renewal in precision and regenerative medicine.
- It holds significant potential for development biology and clinical translation.
- Addressing challenges is crucial for advancing organoid-guided healthcare.
More Related Videos
07:31Author Spotlight: Establishment of Pancreatic Cancer-Derived Tumor Organoids and Fibroblasts From Fresh Tissue
Published on: May 26, 2023
05:57Establishment and Histological Analysis of Esophageal Organoids Modeling the Progression from Normal to Cancerous Tissues
Published on: May 30, 2025